A phase I/II study of neoadjuvant chemoradiotherapy for pancreatic cancer.
- Conditions
- Pancreatic cancer
- Registration Number
- JPRN-UMIN000042932
- Lead Sponsor
- The Jikei University school of medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 58
Not provided
1) Exclude non-curative factors found during radical resection 2) Have overt pulmonary fibrosis or interstitial pneumonia 3) Concomitant with active infectious diseases (HB, HCV, HIV infection, etc.) 4) Have uncontrollable diabetes, heart failure, angina, arrhythmia and myocardial infarction within 6 months of onset 5) Have watery diarrhea 6) Cases using flucytosine and phenytoin 7) Pregnant, lactating and likely or willing to become pregnant 8) Have a serious drug allergy 9) Have active double cancer (not applicable to cases 5 years after complete cure) 10) Have other serious complications 11) Have severe neuropsychiatric symptoms, renal impairment, hearing impairment 12) Chickenpox patients 13) Previous treatment history (surgical excision, chemotherapy, radiation, etc.) for this disease 14) In addition, the doctor in charge judged that it was inappropriate to carry out this study safely.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method